The Optimal Therapy after Progression on Immune Checkpoint Inhibitors in MSI Metastatic Gastrointestinal Cancer Patients: A Multicenter Retrospective Cohort Study.
Chen M, Wang Z, Liu Z, Liu N, Fang W, Zhang H, Jin X, Li J, Zhao W, Qu H, Song F, Chang Z, Li Y, Tang Y, Xu C, Zhang X, Wang X, Peng Z, Cai J, Li J, Shen L.
Chen M, et al. Among authors: li y, li j.
Cancers (Basel). 2022 Oct 21;14(20):5158. doi: 10.3390/cancers14205158.
Cancers (Basel). 2022.
PMID: 36291942
Free PMC article.